Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fmed.2026.1890561.s001BackgroundDonor-derived cell-free DNA (dd-cfDNA) is a noninvasive biomarker for allograft injury in kidney transplant recipients. This single-center study aimed to evaluate the clinical indications for dd-cfDNA testing, its association with biopsy findings, and the comparative utility of dd-cfDNA expressed as a percentage versus absolute copy number.MethodsA retrospective analysis was conducted of 571 dd-cfDNA measurements from 313 kidney transplant recipients at the Charité Berlin Transplant Center from May 2020 to May 2025. The clinical indications for testing, biopsy, and rejection predictors were assessed using multivariable logistic regression and linear regression.ResultsElevated creatinine (29%), elevated urine albumin-to-creatinine ratio (UACR, 10%), donor-specific antibody positivity (10%), history of rejection (9%), immunosuppression reduction (5%), and combined reasons (38%) were the most frequent indications for dd-cfDNA testing. Elevated UACR was the only independent predictor of biopsy (odds ratio [OR], 3.02; 95% confidence interval [CI], 1.39–6.58; p = 0.005). In the biopsy cohort, the dd-cfDNA percentage (OR, 5.46; 95% CI, 2.89–13.70; p = 0.0035) and copies/mL (OR, 7.05; 95% CI, 1.01–21.09; p = 0.0062) independently predicted rejection. ROC analysis indicated good discrimination of rejection for both copies/mL (AUC, 0.781) and percentage (AUC, 0.820). DCA revealed that both dd-cfDNA formats offered greater net clinical benefits for rejection prediction than the conventional markers.ConclusionAlthough biopsy decisions primarily rely on conventional clinical parameters, dd-cfDNA can independently identify rejection and improve decision-making when integrated into multimodal post-transplant monitoring strategies.
Keyword(s):
acute rejection; biomarker; biopsy; donor-derived cell free DNA; Foetal Development and Medicine.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)